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O-GlcNAcylation is a post-translational modification of proteins that controls a variety
of cellular processes, is chronically elevated in diabetes mellitus, and may contribute
to the progression of diabetic complications, including diabetic nephropathy. Our
previous work showed that increases in the O-GlcNAcylation of cellular proteins
impair the homeostatic reaction of the regulatory volume decrease (RVD) after cell
swelling by an unknown mechanism. The activation of the swelling-induced chloride
current IClswell is a key step in RVD, and ICln, a ubiquitous protein involved in the
activation of IClswell, is O-GlcNAcylated. Here, we show that experimentally increased
O-GlcNAcylation of cellular proteins inhibited the endogenous as well as the ICln-
induced IClswell current and prevented RVD in a human renal cell line, while decreases in
O-GlcNAcylation augmented the current magnitude. In parallel, increases or decreases
in O-GlcNAcylation, respectively, weakened or stabilized the binding of ICln to the
intracellular domain of α-integrin, a process that is essential for the activation of
IClswell. Mutation of the putative YinOYang site at Ser67 rendered the ICln-induced
IClswell current unresponsive to O-GlcNAc variations, and the ICln interaction with
α-integrin insensitive to O-GlcNAcylation. In addition, exposure of cells to a hypotonic
solution reduced the O-GlcNAcylation of cellular proteins. Together, these findings
show that O-GlcNAcylation affects RVD by influencing IClswell and further indicate that
hypotonicity may activate IClswell by reducing the O-GlcNAcylation of ICln at Ser67,
therefore permitting its binding to α-integrin. We propose that disturbances in the
regulation of cellular volume may contribute to disease in settings of chronically elevated
O-GlcNAcylation, including diabetic nephropathy.
Keywords: O-GlcNAcylation, IClswell, ICln, α-integrin, regulatory volume decrease, kidney, protein–protein
interaction
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INTRODUCTION
O-GlcNAcylation is a dynamic and abundant post-translational
modification of cytosolic, nuclear, mitochondrial, and
membrane proteins, which consists of the addition of a
single monosaccharide (O-linked β-D-N-acetylglucosamine or
O-GlcNAc) to hydroxyl groups of serine and/or threonine
residues. The substrate for O-GlcNAcylation is uridine
diphosphate-β-N-acetylglucosamine (UDP-GlcNAc), the end
product of the hexosamine biosynthetic pathway (HBP), and its
abundance controls the efficiency of protein O-GlcNAcylation.
Approximately 2–5% of cellular glucose is diverted to the
HBP, which is consequently strongly connected to the nutrient
availability and carbohydrate metabolism (Wells et al., 2001,
2003b; Zachara and Hart, 2006; Zachara et al., 2015; Fisi et al.,
2017). O-GlcNAc modification is reversible and specific and
is tightly controlled by the activity of the enzymes O-GlcNAc-
transferase (OGT) and O-GlcNAcase (OGA), which catalyze the
addition and the removal of O-GlcNAc from target proteins,
respectively (Gloster and Vocadlo, 2010; Yang and Qian, 2017).
O-GlcNAcylation may compete and establish a dynamic
interplay with other post-translational modifications, including
phosphorylation, by occurring on same sites or adjacent
sites (Slawson and Hart, 2011). Amino acids that are either
phosphorylated or O-GlcNAcylated in a mutually exclusive
manner are called YinOYang sites and are crucially involved in
controlling protein activity (Zeidan and Hart, 2010).
O-GlcNAcylation regulates a variety of cellular and molecular
processes including intracellular signaling, gene transcription,
protein–protein interaction, and stability, localization and
expression of proteins (Butkinaree et al., 2010). Consequently,
O-GlcNAc plays a role in numerous physiological and
pathological conditions, including the response to stress,
cancer, neurodegeneration, and diabetes mellitus (Wells
et al., 2001; Zachara et al., 2004; Hart et al., 2007; Fardini
et al., 2013). Specifically, strong positive correlations between
protein O-GlcNAc levels and insulin resistance, glucose toxicity
(McClain and Crook, 1996; Copeland et al., 2008), and chronic
complications of diabetes mellitus (Brownlee, 2001; Buse, 2006;
McLarty et al., 2013) have been well established in cell culture
and animal models (Buse, 2006; Dias and Hart, 2007; Nagy et al.,
2007) as well as in patients (Wang et al., 2009; Park et al., 2010;
Springhorn et al., 2012; Myslicki et al., 2014; Pagesy et al., 2018).
Among the multiple and diverse functions of O-GlcNAcylation,
one of the least studied is the modulation of the regulation of
cellular volume.
The regulation of cellular volume is a homeostatic reaction
essential to normal cell function (Lang et al., 1998; Hoffmann
et al., 2009). Variations of the cellular volume are due to an
imbalance between the intra- and the extracellular osmolality;
may induce alterations in cell morphology, function, and
survival; and therefore require counterbalance. In mammalian
cells, swelling activates a rapid release of KCl and/or non-essential
organic osmolytes accompanied by cellular water (Jakab et al.,
2002). This process is called regulatory volume decrease (RVD)
and permits swollen cells to regain their original volume. The
main conductive pathway leading to the release of Cl− during
RVD is called IClswell (Furst et al., 2002a), and the respective
main molecular entity was identified as the leucine-rich repeat
containing protein 8A (LRRC8A) (Qiu et al., 2014; Voss et al.,
2014; Pedersen et al., 2016), although other channels may also
play a role in this context (Liu et al., 2019; Okada et al., 2019).
Our previous study established a link between
O-GlcNAcylation and RVD. Increasing the cellular O-GlcNAc
levels by a hour pretreatment with glucosamine, PUGNAc, or
high glucose (30 mM) altered the response of Jurkat cells to a
hypotonic stimulus. Specifically, the swelling observed following
exposure of cells to a hypotonic extracellular medium was
augmented and the intracellular water diffusion was reduced
(Nagy et al., 2010). However, the molecular mechanism by
which augmented O-GlcNAcylation affects RVD remains
to be established.
ICln is a ubiquitous, highly conserved, multifunctional protein
that plays a fundamental role in RVD (Paulmichl et al.,
1992; Furst et al., 2006). During a hypotonic stimulus, ICln
is transposed toward the plasma membrane and facilitates
the activation of IClswell (Ritter et al., 2003; Dossena et al.,
2011). Binding of cytosolic ICln to the intracellular domain of
α-integrin is an essential prerequisite for ICln association with the
plasma membrane and IClswell activation and requires a direct
molecular interaction between highly conserved amino acid
motifs of both proteins (Schedlbauer et al., 2019). Specifically,
the sequence (61)ISLHA(65) (single-letter amino acid code;
numbers refer to the amino acid position within the human ICln
protein sequence), located in the β4–β5 loop and β5 sheet of
the pleckstrin homology-like N-terminal portion of ICln (Furst
et al., 2005), appears to be essential for binding to α-integrin as
well as for the ICln-induced activation of IClswell. Interestingly,
ICln is O-GlcNAcylated (Hahne et al., 2013); however, the ICln
O-GlcNAc modification site(s) as well as their physiological
significance are not assessed.
The aim of the present study was to explore the mechanism
by which O-GlcNAcylation affects RVD. Here, we show that
augmented O-GlcNAcylation prevents RVD by reducing the
magnitude of the ion current IClswell. IClswell inhibition results
from O-GlcNAcylation of the protein ICln on serine 67, which
prevents its binding to the intracellular domain of the integrin α
chain. These findings suggest that dysfunction of cellular volume
regulation may contribute to diseases associated with chronic
elevation of O-GlcNAcylation.
MATERIALS AND METHODS
Cell Culture and Transfection
Human embryonic kidney (HEK) 293 Phoenix (DiCiommo
et al., 2004) and HeLa cells [human cervical adenocarcinoma,
CCL-2, obtained from American Type Cell Culture Collection
(ATCC), Manassas, VA, United States] were cultured in
Minimum Essential Eagle Medium (Sigma-Aldrich, St. Louis,
MO, United States) supplemented with 10% fetal bovine serum
(GIBCO, Thermo Fisher, Waltham, MA, United States), 2 mM
L-glutamine, 100 U/ml penicillin, 100 µg/ml streptomycin,
and 1 mM pyruvic acid (sodium salt). NIH/3T3 cells (mouse
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embryonic fibroblasts, CRL-1658, obtained from ATCC) were
cultured in Dulbecco’s Modified Eagle’s Medium (Sigma-Aldrich)
supplemented with 10% bovine calf serum (GIBCO), 100
U/ml penicillin and 100 µg/ml streptomycin. The cells were
maintained at 37◦C, 5% CO2, 95% air, and 100% humidity.
Subcultures were routinely established every second to third day
by seeding the cells into 100-mm diameter Petri dishes following
trypsin/ethylenediaminetetraacetic acid (EDTA) treatment.
For transfection, cells were seeded into six-well plates
or 30-mm diameter Petri dishes, grown overnight to ∼50%
confluence, and transiently transfected with 1–3 µg of plasmid
DNA by the calcium phosphate co-precipitation method (HEK
293 Phoenix) or 1.5–3 µg of plasmid DNA and 3–6 µl
METAFECTENE PRO R© (Biontex, Munich, Germany), following
the manufacturer’s instructions (HeLa and NIH/3T3). For co-
transfection experiments, equimolar amounts of two vectors were
used. Medium was replaced 6–8 h after transfection.
Plasmid Constructs
For electrophysiology experiments, the open reading frames
(ORFs) coding for human ICln (hICln, NCBI Reference
Sequence: NP_001284.1); Canis familiaris ICln (from Madin-
Darby Canine Kidney cells, MDCK ICln, NP_001003288.1);
and the long (OGA-L, NP_036347.1) or short (OGA-S,
NP_001135906.1) isoforms of OGA, OGT (NP_858051.1; all
from HEK 293 Phoenix cells), or integrin αIIbshort (amino
acids 987–1039 of the human integrin αIIb chain, NP_000410.2)
were cloned into the bicistronic mammalian expression vectors
pIRES2EGFP or pIRES2dsRedExpress (Clontech, Mountain
View, CA, United States). The use of a vector bearing the internal
ribosome entry site (IRES) allows for the simultaneous expression
of the protein of interest (either OGT, OGA, integrin αIIbshort,
or ICln) and the transfection marker (either the enhanced green
fluorescent protein EGFP or the red fluorescent protein dsRED)
as two individual proteins from the same bicistronic mRNA,
without the production of fusion proteins (Morgan et al., 1992).
Control experiments were conducted in cells transfected with
the pIRES2EGFP-EGFP vector, where an additional EGFP coding
sequence was cloned into the pIRES2EGFP expression vector.
Consequently, the control vector contained two EGFP coding
sequences (one in the multiple cloning site and one downstream
of the IRES sequence).
Plasmids encoding for ICln Ser67Ala, Thr223Ala, and Ser193∗
were obtained by site-directed mutagenesis of vectors bearing
the wild-type ICln cDNA with the QuikChange Site-Directed
Mutagenesis Kit (Agilent, Santa Clara, CA, United States).
Mutagenesis primers were designed in-house (Gene Runner,
version 5.0.993 Beta) and obtained from Microsynth AG
(Balgach, Switzerland).
To produce fusion proteins for fluorescence resonance
energetic transfer (FRET) experiments, hICln, MDCK ICln,
hOGT, hOGA, or integrin αIIbshort ORFs were cloned into
the pEYFPC1, pEYFPN1, pECFPC1, or pECFPN1 mammalian
expression vectors (Clontech) in frame with the ORF of the
enhanced yellow fluorescent protein (EYFP) or enhanced cyan
fluorescent protein (ECFP).
All plasmid inserts were sequenced prior to their use in
experiments (Microsynth AG).
Manipulation of O-GlcNAcylation of
Cellular Proteins
To increase the O-GlcNAcylation levels of cellular proteins, cells
were incubated for 1 h in complete medium with 20 mM D-
glucose, 5 mM glucosamine, 100 µM O-(2-acetamido-2-deoxy-
D-glucopyranosylidene)amino N-phenyl carbamate (PUGNAc;
Sigma Aldrich), 100 µM PUGNAc, and 5 mM glucosamine (Nagy
et al., 2010) or were transfected for 24 h with OGT. To reduce the
O-GlcNAcylation levels of proteins, cells were transfected for 24 h
with OGA. PUGNAc was dissolved in 100% dimethyl sulfoxide
(DMSO) and stored at −20◦C. To obtain equal osmolarity of
control incubation media, 20 mM mannitol and 5 mM D-glucose
were used instead of 20 mM D-glucose and 5 mM glucosamine.
Patch Clamp
Cells were transferred to glass coverslips (10-mm diameter)
8 h after transfection, and electrophysiology measurements were
performed 24–32 h after transfection. Single cells expressing
the transfection marker EGFP, dsRed, or both could be
identified by fluorescence microscopy using FITC (excitation:
480/30x, dicroic: 505 dclp, and emission: 535/40 m) and TRITC
(excitation: 540/25x, dicroic: 565 dclp, and emission: 605/55 m)
filter sets. Selected cells were voltage-clamped using the whole-
cell patch-clamp technique as previously described (Gandini
et al., 2008; Dossena et al., 2011; Tamma et al., 2011; Morabito
et al., 2017; Schedlbauer et al., 2019). The resistance of the
glass pipettes was 3–8 M when filled with the pipette solution
(CsCl 125 mM, MgCl2 5 mM, EGTA 11 mM, ATP Mg2+
salt 2 mM, HEPES 10 mM, pH 7.2 adjusted with CsOH,
and 300 mOsm/kg H2O). Fast exchange of the isotonic bath
solution (NaCl 125 mM, CaCl2 2.5 mM, MgCl2 2.5 mM, HEPES
10 mM, mannitol 40 mM, pH 7.4 adjusted with NaOH, and
300 mOsm/kg H2O) with a hypotonic bath solution (NaCl
125 mM, CaCl2 2.5 mM, MgCl2 2.5 mM, HEPES 10 mM, pH
7.4 adjusted with NaOH, and 260 mOsm/kg H2O) was obtained
using a perfusion system with a flow rate of 5 ml/min and a
bath volume of ∼300 µl. For data acquisition, an EPC10 USB
amplifier (HEKA Elektronik, Lambrecht, Germany) controlled
by a Macintosh computer running the Patch Master (v2x32,
HEKA Elektronik) software was used. Access resistance was
monitored throughout the recordings and never exceeded thrice
the recording electrode resistance. Fast and slow capacitance
were compensated. All current measurements were filtered at
2.9 kHz and digitized at 50 kHz. To monitor the activation of
the swelling-activated chloride current (IClswell), cells were held
at 0 mV and step pulses of 400-ms duration were applied from
0 to 40 mV every 20 s. To establish the current to voltage (IV)
relationship, step pulses of 500-ms duration were applied every
5 or 10 min from −120 to +100 mV in 20-mV increments
from a holding potential of 0 mV. For data analysis, Fit Master
(v2x32, HEKA Elektronik) and Excel (Microsoft, United States)
software were used. The current values (pA) were normalized
to the membrane capacitance (pF) to obtain the current density
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(pA/pF). Each data set was obtained from cells from at least three
independent subcultures with control experiments in cells of the
same subculture.
Western Blotting
Cells were washed twice with ice-cold phosphate-buffered saline
(PBS) and lysed on ice in a buffer containing 20 mM Tris-HCl,
150 mM NaCl, 1 mM EDTA, 0.1% NP40, and protease inhibitor
cocktail (Roche, Basel, Switzerland). Subsequently, cellular debris
was discarded by centrifugation at 16,000 × g for 30 min at
4◦C and the supernatant was collected. Typically, 10 µg of total
proteins were separated by a 7.5% polyacrylamide gel containing
0.1% SDS and electroblotted using a polyvinylidene fluoride
membrane (Bio-Rad, Basel, Switzerland) by applying a constant
voltage (75 V) for 2 h at 4◦C. Membranes were blocked for
1 h at room temperature in 5% bovine serum albumin (BSA)
diluted in Tris-buffered saline (150 mM NaCl and 15 mM
Tris-HCl) containing 0.1% Tween 20 (TBST) and incubated
overnight at 4◦C with the following primary antibodies: mouse
monoclonal IgM CTD110.6 (Cell Signaling Technology, Inc.,
Danvers, MA, United States), highly specific for O-glycosylated
proteins (Kneass and Marchase, 2004), diluted 1:1,000, or rabbit
polyclonal IgG against amino acids 151–164 of CLNS1A (Sigma
Aldrich), diluted 1:2,000. The housekeeping proteins GAPDH or
β-actin were detected with a goat (GenScript, Piscataway, NJ,
United States) or rabbit (Cell Signaling) polyclonal antibody,
respectively, both diluted 1:1,000. Membranes were washed three
times in TBST and incubated for 1 h at room temperature with
the secondary antibodies diluted 1:10,000 in PBS and 5% BSA
(goat anti-mouse IgM, IRD-680 RD, donkey anti-goat, IRD-
800 CW, or goat anti-rabbit, IRD-800 CW, all from LI-COR,
Lincoln, NE, United States). The signal of immunocomplexes
was revealed using the Odyssey (LI-COR) infrared imaging




Cells were transferred to round 3-cm diameter glass slides 32 h
post-transfection and fixed for 30 min with 4% paraformaldehyde
in Hanks’ Balanced Salt Solution (HBSS) 48 h post-transfection.
Imaging was performed in HBSS at room temperature. The
FRET acceptor EYFP was excited with the 514-nm line of the
Argon laser, and the emission was detected in the 525–600-nm
range. The FRET donor ECFP was excited with the 405-nm
laser, and the emission was detected in the 450–490-nm range.
Imaging was performed by sequential acquisition with FRET
AB-Wizard with a Leica TCS SP5II AOBS confocal microscope
(Leica Microsystems, Wetzlar, Germany) equipped with a HCX
PL APO 63x/1.20 Lambda blue water immersion objective and
controlled by the LAS AF software (version 2.7.3.9723, Leica
Microsystems). EYFP photobleaching in whole cells was obtained
with 15 sequential illuminations at 514 nm (zoom factor 8×).
FRET efficiency was calculated using the following formula:
FRET efficiency = 1 − ECFPpre/ECFPpost (1)
ECFPpre and ECFPpost refer to the ECFP intensity before and
after EYFP photobleaching, respectively, and were determined
either in the bleaching regions of interest (ROI) or in plasma
membrane ROIs, as indicated. In the latter case, ROIs were
drawn within the bleaching ROI, on the pre-bleaching EYFP
image, in areas with a clear targeting of αIIbs-EYFP at the
cell periphery.
Cell Volume Measurements
Cell volume measurements were performed as previously
described (Morabito et al., 2013, 2014, 2017). Briefly, HEK
293 Phoenix cells were transferred to round 3-cm diameter
glass slides and successively placed in a perfusion chamber.
Cell volume measurements were performed on cells sequentially
exposed to the following: isotonic solution for 1 min and
hypotonic solution (∼15% reduction of osmolality by omission
of mannitol) for 2–3 min. Cell volume measurements were
performed on roundish cells. For each experiment, 100–150
images/cell (1 image/1,293 s) were taken with a phase contrast
microscope (Leica DMI 6000, with a HCX PL APO 63x/1.20
Lambda blue water immersion objective; Leica Microsystems).
Cell diameter was measured for each image and, assuming the
cell as a sphere, cell volume was calculated and expressed as
V/V0, where V and V0 represent the volume of a cell at a




For immunoprecipitation, cells were lysed on ice for 30 min
in IP buffer (25 mM Tris-HCl, pH 7.4, 150 mM NaCl, 1 mM
EDTA, 1% Triton X-100, 5% glycerol, 0.05% Na-azide, protease
inhibitor cocktail, and 50 µM of PUGNAc). Next, the samples
were sonicated for 5 s at 30% power (Bandelin Sonopuls). Finally,
the samples were centrifuged at 4◦C for 10 min at 3,000 rpm,
and the supernatants were incubated with anti-ICln antibodies
#1 or #2 at 4◦C overnight on a rotary shaker. Anti-ICln #1 is a
polyclonal antibody raised in rabbits against amino acids 214–237
of human ICln, while anti-ICln #2 (Santa Cruz Biotechnology,
Cat. No.: SC-393525) is a mouse monoclonal antibody. Protein
A-Sepharose beads (Sigma-Aldrich) were prepared as follows:
beads were washed in 800 µl IP buffer and incubated for 30 min
in 3% BSA/IP buffer at 4◦C on a shaker to block non-specific
binding sites. Next, immunoprecipitates were incubated with the
Protein A beads on a rotary shaker at 4◦C for 3 h. Next, the
beads were washed in 1 ml of IP buffer twice, the last wash
buffer was removed carefully, and 50 µl of elution buffer (0.1
M glycine, pH 2.8) was added to the beads and incubated for
10 min at room temperature. The eluate (IP) was kept and
6 µl of 1.5 M Tris-HCl (pH 8.8) was added to neutralize the
pH. During the process, lysates including the antibodies (input)
and flow-through (FT) from the beads were collected. All of
the collected samples (input, FT, and IP) were adjusted with
4X sample buffer and processed on 7.5% polyacrylamide gel
electrophoresis. The proteins were either transferred to PVDF
membranes for western blot analysis or the gel was directly
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stained with Coomassie Brilliant Blue R-250 for further mass
spectrometry analysis.
For mass spectrometry (MS), the protein bands of interest
were cut out from the Coomassie-stained gels and digested by
trypsin using the in-gel digestion protocol as described (Szabo
et al., 2012). Briefly, excised gel bands were cut into small pieces,
destained in 25 mM NH4HCO3 and 50% acetonitrile, dehydrated
with acetonitrile, and dried. The gel pieces were rehydrated
in 12.5 ng/µl trypsin (Promega, Madison, WI, United States)
solution (in 25 mM NH4HCO3) and incubated overnight at 37◦C.
Peptides were extracted with 5% formic acid and twice with 60%
acetonitrile in 1% formic acid.
Digested protein samples were analyzed using a Waters
nanoACQUITY UPLC System coupled with a Thermo Q
Exactive plus mass spectrometer. Forty-five-minute long
gradients from 3% to 40% acetonitrile/water were applied on a
Waters BEH130 C18 75 µm × 100 mm column with 1.7 µm
particle size C18 packing. The mass spectrometer was operated
in DDA mode, and the 12 most intensive peptides were selected
for fragmentation in each MS scan.
From all acquired data, peaklists were generated by the
Msconvert tool from ProteoWizard (Chambers et al., 2012).
All MS/MS samples were analyzed using Mascot 2.2.06
(Matrix Science, London, UK). Mascot was set up to search
the UniProt Human proteome database (2017.03 release,
70,942 entries) assuming digestion by trypsin and allowing
up to two missed cleavage sites. Database searching was
carried out with a fragment ion mass tolerance of 0.1 Da
and a parent ion tolerance of 10 ppm. The iodoacetamide
derivative of cysteine was specified as a fixed modification,
and oxidation of methionine, N-acetyl-glycosylation of
serine and threonine, acetylation of protein N-terminal,
and formylation of peptide N-terminal were specified as a
variable modification in Mascot. Database search results were
validated, and MS/MS spectra were annotated in PeptideShaker
1.16.45 (Vaudel et al., 2015).
Immunocytochemistry
HeLa cells were grown on coverslips until ∼50% confluence and
treated with either 100 µM PUGNAc and 5 mM glucosamine
or the vehicle for 1 h at 37◦C. Following this, the cells were
exposed to 300 mOsmol isotonic (mannitol 100 mM, NaCl
87.5 mM, CaCl2 2.5 mM, MgCl2 2.5 mM, HEPES 10 mM,
pH 7.4) or 200 mOsmol hypotonic (NaCl 87.5 mM, CaCl2
2.5 mM, MgCl2 2.5 mM, HEPES 10 mM, pH 7.4) solution
for 15 min. Next, cells were fixed in 10 v/v% PBS-buffered
formaldehyde for 30 min at room temperature. To avoid
formaldehyde autofluorescence, the coverslips were quenched
with 50 mM ammonium chloride for 10 min. The cells were
permeabilized with 0.25 v/v% Triton-X 100 for 10 min. Non-
specific sites were blocked with 5% bovine serum albumin
(Sigma-Aldrich) in PBS for 30 min, and then, the coverslips
were incubated at room temperature with the primary antibodies
in 5 w/v% BSA/PBS for 2 h. The primary antibodies and
their dilutions were the following: CTD110.6 (1:200) and
rabbit anti-ICln (1:100). After rinsing three times with PBS,
samples were incubated with the corresponding secondary
antibodies for 1 h in the dark. Finally, coverslips were mounted
with VECTASHIELD (Vector Laboratories, Burlingame, CA,
United States) mounting medium. Image acquisition was
performed with a Zeiss LSM 710 confocal scanning microscope
(Carl Zeiss AG, Oberkochen, Germany) equipped with the
ZEN software (ver2.3, Carl Zeiss AG, Oberkochen, Germany)
and a 63× objective. Alexa Fluor 488 (ICln) and Texas
Red (CTD110.6) fluorescence channels were used for image
acquisition (excitation 488 and 594 nm, emission 518 and
624 nm, respectively).
Bioinformatic Analysis
The amino acid sequence of human ICln (NP_001284.1)
was analyzed with the YinOYang WWW server
(http://www.cbs.dtu.dk/services/YinOYang/), which produces
neural network predictions for O-β-GlcNAc attachment
sites in eukaryotic protein sequences (Gupta and Brunak,
2002). This server can also use NetPhos, which predicts
serine, threonine, or tyrosine phosphorylation sites in
eukaryotic proteins, to identify possible phosphorylated
sites that, when coinciding with O-GlcNAcylation sites,
represent “YinOYang” sites (Blom et al., 2004). In addition, the
GlycoMine (http://glycomine.erc.monash.edu/Lab/GlycoMine/)
bioinformatics tool was used to predict O-linked glycosylation
(Li et al., 2015).
Statistical Analysis
All data are expressed as arithmetic means ± standard errors
of the mean. For statistical analysis and graphics, GraphPad
Prism (version 5.0b for Mac OS, San Diego, CA, United States)
and Excel (Microsoft) software were used. Significant differences
between mean values were determined by the unpaired Student’s
t-test or ANOVA with Bonferroni’s or Dunnett’s post-test, as
appropriate. Statistically significant differences were determined
at ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001; (n) corresponds to the
number of independent measurements.
RESULTS
Manipulation of O-GlcNAcylation of
Cellular Proteins
Incubation of cells with O-GlcNAc precursors such as D-
glucose or glucosamine, pharmacological inhibition of OGA
with PUGNAc, as well as overexpression of OGT or OGA
have formerly been used to experimentally increase or decrease
O-GlcNAcylation levels of cellular proteins (Champattanachai
et al., 2008; Yuzwa and Vocadlo, 2014; Ferron et al., 2018).
Here, incubation of HEK 293 Phoenix cells for 1 h with 20 mM
D-glucose, 5 mM glucosamine, or 100 µM PUGNAc failed to
significantly increase O-GlcNAcylation levels of cellular proteins
(Figures 1A–C and Table 1). However, combining 100 µM
PUGNAc with 5 mM glucosamine increased O-GlcNAcylation
up to 3.6-fold of control levels (Figure 1D and Table 1).
Transfection of cells with OGT was the most effective maneuver
and increased O-GlcNAcylation of 6.5-fold compared to cells
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FIGURE 1 | Manipulation of O-GlcNAcylation levels of cellular proteins. HEK 293 Phoenix cells were incubated for 1 h in complete medium with (A) 20 mM mannitol
(control) or D-glucose, (B) 5 mM D-glucose (control) or glucosamine, (C) 0.1% DMSO (control) or 100 µM PUGNAc, (D) 0.1% DMSO plus 5 mM D-glucose (control)
or 100 µM PUGNAc plus 5 mM glucosamine, or (E) were transfected for 24 h with the pIRES2EGFP vector coding for OGT, OGA-L, or OGA-S or with the
pIRES2EGFP-EGFP vector as a control. The expression levels of cellular O-GlcNAc-modified proteins determined via western blot were quantified by densitometry
and normalized to the housekeeping protein β-actin. n = 3, ∗∗p < 0.01, ∗∗∗p < 0.001, two-tailed, unpaired Student’s t-test or one-way ANOVA with Dunnett’s
post-test. (n) refers to the number of independent samples. C, control; T, treatment; DMSO, dimethyl sulfoxide; OGT, O-GlcNAc-transferase; OGA, O-GlcNAcase.
transfected with a control vector (Figure 1E and Table 1).
Conversely, cells expressing either OGA-L or its splicing variant
OGA-S showed a significant reduction in O-GlcNAcylation
of cellular proteins, which was more pronounced with OGA-
L (Figure 1E and Table 1). Hence, the catalytic activity
of OGA-S was found to be lower than that of OGA-L
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TABLE 1 | Effect of manipulation of O-GlcNAcylation of cellular proteins on the current IClswell.









20 mM D-glucose +8% (n.s.) n.s. n.s. n.p.
5 mM glucosamine +5% (n.s.) n.s. n.s. n.p.
100 µM PUGNAc +25% (n.s.) n.s. n.s. n.p.
100 µM PUGNAc plus 5 mM
glucosamine
+265% n.s. −55% n.s.
OGT +545% −38% −58% −38%
OGA-S −60% n.s. n.p. n.p.
OGA-L −69% n.s. +158% n.s.
The % variation in O-GlcNAcylation was calculated from western blot data shown in Figure 1. The % variation in IClswell intensity was calculated at +100 mV. + and −
denote an increase and decrease compared to the corresponding control, respectively. n.s., not significant; n.p., not performed.
(Kim et al., 2006). Therefore, only OGA-L was used in
further experiments.
Increased O-GlcNAcylation of Cellular
Proteins Inhibits the Endogenous
IClswell Current
To assess the possible influence of O-GlcNAc on the endogenous
swelling-activated chloride current IClswell, the patch-clamp
technique in whole-cell configuration was used in untransfected
cells in which the O-GlcNAcylation of cellular proteins was
experimentally increased or decreased. Cells were initially
kept in an extracellular isotonic solution. In these conditions,
currents were very small and undistinguishable from leakage
currents. Exposure of cells to an extracellular hypotonic solution
activated a current with outward rectification and slow time-
dependent inactivation at voltages higher than +40 mV. The
reversal potential (Erev) of this current was 0 mV, which
corresponds to the equilibrium potential of chloride with the
experimental solutions used and is therefore indicative of a
chloride selective current (Supplementary Figure S1). All of
the above-mentioned characteristics represent the biophysical
fingerprints of IClswell (Furst et al., 2002a). Pre-incubation
of HEK 293 Phoenix cells for 1 h with 20 mM D-glucose,
5 mM glucosamine, or 100 µM PUGNAc failed to increase
O-GlcNAcylation of cellular proteins (Figures 1A–C) and did
not modify the endogenous IClswell current (Supplementary
Figures S1–S3 and Table 1). Pre-incubating cells with 100 µM
PUGNAc plus 5 mM glucosamine, which was effective in
increasing O-GlcNAcylation levels in these cells (Figure 1D),
also did not significantly modify the endogenous IClswell
current (Supplementary Figure S4 and Table 1). In contrast,
in cells transfected with OGT, which was twice as effective
as 100 µM PUGNAc plus 5 mM glucosamine in increasing
O-GlcNAcylation levels, IClswell magnitude was significantly
reduced and the activation in time was delayed in comparison
to control conditions (Figure 2 and Table 1). In cells transfected
with OGA-L, IClswell showed a tendency to an increase,
which, however, was not statistically significant (Supplementary
Figure S5).
Increased O-GlcNAcylation of Cellular
Proteins Inhibits the ICln-Induced
IClswell Current
Overexpression of the heterologous protein ICln up-regulates
IClswell in several cell types (Paulmichl et al., 1992; Hubert
et al., 2000; Furst et al., 2002b; Dossena et al., 2011; Schedlbauer
et al., 2019) (Supplementary Figure S6). In these cells, the
apparent IClswell is the sum of the endogenous IClswell and
the ICln-induced IClswell. Similarly to what was observed
for the endogenous IClswell current, pre-incubation of cells
with 20 mM D-glucose, 5 mM glucosamine, or 100 µM
PUGNAc failed to modify IClswell in ICln-transfected cells
(Supplementary Figures S7–S9 and Table 1). In contrast,
treatment with 100 µM PUGNAc plus 5 mM glucosamine,
as well as OGT overexpression, significantly inhibited IClswell
(Figures 3, 4 and Table 1). As 5 mM glucosamine plus 100 µM
PUGNAc had no effect on the endogenous current, the 55%
inhibition of IClswell that was observed in ICln-transfected
cells (Table 1) must have arisen from inhibition of the ICln-
induced current. Similarly, the OGT-induced IClswell inhibition
in ICln-transfected cells (58%) most likely represents the sum
of inhibition of (i) the endogenous IClswell (38%, Table 1)
and (ii) the ICln-induced current. Conversely, IClswell was
significantly up-regulated by OGA-L in ICln-transfected cells
(Figure 5 and Table 1).
Increased O-GlcNAcylation of Cellular
Proteins Prevents RVD
To assess the effects of an increased O-GlcNAcylation on RVD,
HEK 293 Phoenix cells were treated with 100 µM PUGNAc
plus 5 mM glucosamine or 0.1% DMSO plus 5 mM glucose
as control. The cell size was monitored before and during
an osmotic stress, and cell volume changes were expressed as
V/V0. As expected, the hypotonic shock promptly induced cell
swelling followed by RVD activation in control cells, which
regained their original volume. In contrast, in cells treated with
100 µM PUGNAc and 5 mM glucosamine, cell swelling was
more prominent and, importantly, was not followed by an RVD
phase (Figure 6).
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FIGURE 2 | O-GlcNAc elevation obtained by OGT overexpression blunts IClswell in native cells. IClswell activation was monitored in HEK 293 Phoenix cells
transfected for 24 h with OGT and the transfection marker EGFP as separate proteins or a control vector. Single transfected cells were selected and voltage clamped
using the whole-cell patch-clamp technique. (A) Original recordings obtained in isotonic (upper panels) and hypotonic (lower panels) extracellular solutions in control
(left panels) or OGT-transfected (right panels) cells stimulated with voltage increments of 20 mV from –120 to +100 mV applied from a holding potential of 0 mV
(lower right inset). (B) Current density-to-voltage relationship determined after a 10-min exposure to the extracellular hypotonic solution (left) and current
density-to-time relationship (right) of IClswell in OGT-transfected and control cells. *p < 0.05, unpaired Student’s t-test. (n) refers to the number of cells. OGT,
O-GlcNAc-transferase; EGFP, enhanced green fluorescent protein.
The C-Terminus of ICln Is O-GlcNAc
Modified
Mass spectrometry was used to identify the ICln amino acids
that are O-GlcNAcylated. After overexpressing ICln in HEK 293
Phoenix cells and treating the cells with 100 µM PUGNAc and
5 mM glucosamine, we successfully identified the ICln protein
from immunoprecipitated samples with up to 90% sequence
coverage. Out of the 32 individual peptides found, we detected
O-GlcNAc modification on peptide 187–205. Figure 7A reports
the analysis of the charge state 3+ of this peptide. The O-GlcNAc-
modified peptide has a mass/charge (m/z) value of 754.014
while its unmodified counterpart has an m/z value of 696.3258.
Supplementary Figure S10 demonstrates the analysis of the
same peptide with a charge state of 2+. Unfortunately, no b- or
y-ions that carried the O-GlcNAc modification could be found;
therefore, the exact O-GlcNAc site could not be discerned (there
are four Ser representing potential O-GlcNAcylation sites on
this peptide, Figure 7B). However, it is worth noting that both
analyses found peaks that corresponded to the m/z value of
GlcNAc residues and probably resulted from a loss of GlcNAc
from the parent ion. In addition, we detected phosphorylation at
Ser223 on peptide 206–236 (Figure 7B).
O-GlcNAcylation of the C-Terminus of
ICln Is Not Involved in Modulating
IClswell
Based on the MS results, two mutations were designed in
order to prevent ICln O-GlcNAcylation, i.e., Ser193∗ (nucleotides
coding for Ser193 were substituted by a STOP codon) and
Thr223Ala (Figure 7B). The first mutation leads to an early
termination of translation with consequent protein truncation.
The mutant protein lacks all O-GlcNAcylation sites, including
Ser193. Thr223 is a phosphorylated amino acid with high
likelihood of O-Glycosylation (Supplementary Figures S11, S12)
Frontiers in Cell and Developmental Biology | www.frontiersin.org 8 November 2020 | Volume 8 | Article 607080
fcell-08-607080 November 12, 2020 Time: 15:27 # 9
Costa et al. O-GlcNAcylation Alters the Regulation of Cellular Volume
FIGURE 3 | O-GlcNAc elevation obtained by pre-incubation of cells with PUGNAc and glucosamine blunts IClswell in ICln-transfected cells. IClswell activation was
monitored in HEK 293 Phoenix cells transfected for 24 h with ICln as well as the transfection marker EGFP as separate proteins. Single transfected cells were
selected and voltage clamped using the whole-cell patch-clamp technique. (A) Original recordings obtained in isotonic (upper panels) and hypotonic (lower panels)
extracellular solutions in cells pre-incubated for 1 h with 0.1% DMSO plus 5 mM D-glucose (left panels) or 100 µM PUGNAc plus 5 mM glucosamine (right panels)
and stimulated with voltage increments of 20 mV from –120 to +100 mV applied from a holding potential of 0 mV (lower right inset). (B) Current density-to-voltage
relationship determined after a 20-min exposure to the extracellular hypotonic solution (left) and current density-to-time relationship (right) of IClswell in cells
pre-incubated with 100 µM PUGNAc plus 5 mM glucosamine or the vehicle. *p < 0.05, unpaired Student’s t-test. (n) refers to the number of cells. EGFP, enhanced
green fluorescent protein.
and therefore a potential YinOYang site. The second mutation
converts this amino acid in the non-modifiable Ala. First, the
expression of the ICln mutants and their ability of up-regulating
IClswell were verified. Subsequently, the effect of an increased
O-GlcNAcylation of cellular proteins was probed on the mutant
ICln-induced current.
ICln expression in cells transfected with ICln Thr223Ala
and Ser193∗ was doubled compared to the expression of the
endogenous ICln in untransfected cells and was indistinguishable
from that of cells transfected with wild-type ICln (Figure 8A).
ICln Thr223Ala was fully functional, i.e., able of up-regulating
IClswell to the level of ICln wild type (Figure 8B). In contrast,
ICln Ser193∗ lost most of its activity, and only a small residual
current, which was above the level of the endogenous IClswell,
could be measured in transfected cells (Figure 8C).
Similarly to what was observed for the wild-type ICln-
induced current, the ICln Thr223Ala-induced IClswell, as
well as the residual ICln Ser193∗-induced current, were
inhibited by increases in the O-GlcNAcylation of cellular
proteins induced by incubation of cells with PUGNAc and
glucosamine (Figure 9). As pre-incubation of cells with
PUGNAc plus glucosamine had no effect on the endogenous
IClswell (Supplementary Figure S4), the inhibitory effect
observed in cells transfected with ICln Thr223Ala or ICln
Ser193∗ must arise from inhibition of the mutant ICln-induced
current. These data clearly show that O-GlcNAcylation of
ICln on Ser193 or Thr223 is not involved in suppressing
IClswell and strongly suggest that the O-GlcNAcylation site
involved in controlling the ICln-induced current is located
upstream of Ser193.
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FIGURE 4 | O-GlcNAc elevation obtained by OGT overexpression blunts IClswell in ICln-transfected cells. IClswell activation was monitored in HEK 293 Phoenix
cells transfected for 24 h with ICln and OGT or ICln and a control vector. Transfection markers were dsRed for ICln and EGFP for OGT. Single cells expressing both
transfection markers were selected and voltage clamped using the whole-cell patch-clamp technique. (A) Original recordings obtained in isotonic (upper panels) and
hypotonic (lower panels) extracellular solutions in control (left panels) or OGT-transfected (right panels) cells stimulated with voltage increments of 20 mV from –120
to +100 mV applied from a holding potential of 0 mV (lower right inset). (B) Current density-to-voltage relationship determined after a 10-min exposure to the
extracellular hypotonic solution (left) and current density-to-time relationship (right) of IClswell in OGT-transfected and control cells. *p < 0.05, unpaired Student’s
t-test. (n) refers to the number of cells. OGT, O-GlcNAc-transferase; EGFP, enhanced green fluorescent protein.
Ser67 Confers to ICln Sensitivity to
O-GlcNAcylation
Upstream of ICln Ser193, there is a predicted YinOYang site at
Ser67 (Supplementary Figure S11). This latter site is of particular
interest as it lies in close proximity to the (61)ISLHA(65) motif,
which is crucially involved in ICln binding to the intracellular
domain of α-integrin and controls ICln function (Schedlbauer
et al., 2019). Therefore, we decided to determine whether this
site is involved in modulating ICln function following variation
of O-GlcNAc levels. ICln Ser67Ala is fully functional, i.e., capable
of up-regulating IClswell to an extent indistinguishable from that
of wild-type ICln (Figure 8D). However, the current induced by
this ICln mutant is insensitive to increases or decreases in the
O-GlcNAcylation of cellular proteins (Figure 10). In particular,
OGT overexpression induced a non-significant decrease (38%)
in IClswell (Figure 10B and Table 1), which reflected the
inhibition of the endogenous current (Figure 2 and Table 1).
These experiments strongly suggest that O-GlcNAcylation of ICln
at Ser67 inhibits IClswell.
ICln Interacts With OGT
Conjugation of O-GlcNAc to a protein requires a direct molecular
interaction with OGT. To study this phenomenon, FRET between
OGT and ICln was measured. This technique requires the
transfection of the proteins of interest fused to fluorophores
serving as the FRET donor and acceptor. In this study, ECFP and
EYFP were used as the FRET donor and acceptor, respectively.
EYFP fusion to the N-terminus of OGT did not affect its catalytic
activity (Figure 11A) and was therefore used in experiments.
EYFP-OGT gave a significant FRET with ICln-ECFP, which was
reduced following mutation of Ser67. In contrast, FRET between
EYFP-OGA and ICln did not exceed the stochastic FRET of
the negative control. These results indicate that, in unstimulated
cells, ICln preferentially interacts with OGT rather than OGA,
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FIGURE 5 | O-GlcNAc reduction obtained by OGA-L overexpression upregulates IClswell in ICln-transfected cells. IClswell activation was monitored in HEK 293
Phoenix cells transfected for 24 h with ICln and OGA-L or ICln and a control vector. Transfection markers were dsRed for ICln and EGFP for OGA-L. Single cells
expressing both transfection markers were selected and voltage clamped using the whole-cell patch-clamp technique. (A) Original recordings obtained in isotonic
(upper panels) and hypotonic (lower panels) extracellular solutions in control (left panels) or OGA-L-transfected (right panels) cells stimulated with voltage increments
of 20 mV from –120 to +100 mV applied from a holding potential of 0 mV (lower right inset). (B) Current density-to-voltage relationship determined after a 20-min
exposure to the extracellular hypotonic solution (left) and current density-to-time relationship (right) of IClswell in OGA-L-transfected and control cells. *p < 0.05,
unpaired Student’s t-test. (n) refers to the number of cells. EGFP, enhanced green fluorescent protein; OGA, O-GlcNAcase.
thus suggesting that ICln is constitutively O-GlcNAcylated. The
ICln–OGT interaction is destabilized by mutation of Ser67,
which may therefore represent the ICln O-GlcNAcylation site.
The relatively small signal-to-noise ration of ICln–OGT FRET
indicates that the interaction between the two proteins is dynamic
and transient, which is consistent with the characteristics of a
reversible interaction between an enzyme and its target.
O-GlcNAcylation of ICln at Ser67
Prevents Its Interaction With α-Integrin
ICln establishes a direct molecular interaction with the
intracellular domain of α-integrin (Larkin et al., 2004,
2009; Daxecker et al., 2008) (Figure 12), and perturbation
of this interaction affects IClswell activation (Schedlbauer
et al., 2019). Surprisingly, the interaction between the non-
glycosylatable/non-phosphorylatable ICln Ser67Ala and αIIb
integrin measured by FRET was stronger than the interaction
between wild-type ICln and αIIb integrin (Figure 12B). This
finding suggests that post-translational modification of Ser67
weakens the binding of ICln to α-integrin. To further substantiate
this hypothesis, the interaction between wild type and Ser67Ala
ICln was measured following increases or decreases in the
O-GlcNAcylation of cellular proteins obtained by incubation
of cells with PUGNAc and glucosamine or transfection with
OGA-L, respectively. In line with the hypothesis, elevation of
O-GlcNAcylation reduced the FRET between wild-type ICln and
α-integrin but, importantly, did not affect the FRET between
Ser67Ala ICln and α-integrin (Figure 12C). This confirms that
O-GlcNAcylation of Ser67 reduces the ICln/integrin interaction
and further suggests that a fraction of the ICln protein pool is
constitutively O-GlcNAcylated. In line with these hypotheses,
reduction of O-GlcNAcylation increased the FRET between wild-
type ICln and α-integrin. Again, Ser67Ala ICln was unresponsive
to O-GlcNAcylation changes (Figure 12D).
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FIGURE 6 | O-GlcNAc elevation affects RVD. (A) HEK 293 Phoenix cells were
incubated for 1 h with 100 µM PUGNAc plus 5 mM glucosamine (n = 4) or
0.1% DMSO plus 5 mM glucose as the control (n = 5), initially kept in
extracellular isotonic solution and then submitted to hypotonic stress.
(B) V/V0 values determined in extracellular isotonic solution and 30 s
(swelling) and 160 s (RVD) after exposure to the hypotonic solution. (n) refers
to the number of cells. Data are representative of two independent
experiments leading to similar results. *p < 0.05, ***p < 0.001, two-way
ANOVA with Bonferroni’s post-test. RVD, regulatory volume decrease.
Hypotonicity Reduces O-GlcNAcylation
of Cellular Proteins
To assess the dynamic nature of protein O-GlcNAc modification
upon direct changes during cell volume regulation, we exposed
HeLa cells to 200 mOsmol hypotonic challenge. As shown in
Figure 13, hypotonicity significantly reduced the fluorescence
intensity corresponding to O-GlcNAc levels. Interestingly, this
effect was also detected when O-GlcNAc levels were previously
elevated by PUGNAc and glucosamine treatment.
DISCUSSION
Since the discovery of O-GlcNAc modification, more than
∼4,000 protein targets have been identified (Ma and Hart, 2014).
A large number of O-GlcNAcylated proteins are involved in
the regulation of many cellular events, including intracellular
signaling, gene transcription, cellular metabolism, and stress
responses (Butkinaree et al., 2010; Hart, 2014); therefore, it
is not surprising that improper O-GlcNAcylation contributes
to the development of disease (Hart et al., 2011). Indeed,
O-GlcNAcylation is associated with an increasing number of
pathological states, such as type II diabetes mellitus, diabetic
complications (Vaidyanathan and Wells, 2014; Peterson and
Hart, 2016), insulin resistance (Wells et al., 2003a), cancer
(Stowell et al., 2015), and neurodegeneration (Lagerlof and Hart,
2014; Banerjee et al., 2016; Hart, 2019). Therefore, uncovering the
involvement of O-GlcNAcylation in a given pathological process
and the identification of the respective protein targets could open
the way to novel therapeutic strategies.
The alteration of RVD by increases in the O-GlcNAcylation
of cellular proteins was first reported in Jurkat cells, an
immortalized line of human T lymphocytes (Nagy et al., 2010).
In this study, exposure of cells for 1 h to 30 mM D-glucose
or 5 mM glucosamine was sufficient to significantly alter the
levels of O-GlcNAcylated proteins as well as the osmotic response
of cells to hypotonicity, leading to an increased swelling and
delayed RVD. In HEK 293 Phoenix cells, significant increases
in O-GlcNAc levels required incubation with 100 µM PUGNAc
plus 5 mM glucosamine for 1 h (Figure 1D). In agreement
with the above-mentioned study, these cells swelled more than
control cells when stimulated by hypotonicity, and their RVD was
abrogated (Figure 6). These data show that alteration of osmotic
resistance by increases in the O-GlcNAcylation of cellular
proteins is not a feature restricted to Jurkat cells and consists of
two components, i.e., increased swelling and inefficient or absent
RVD. Jurkat cells seem more sensitive to O-GlcNAc precursors
than HEK 293 Phoenix cells. This may be linked to differential
expression of glucose transporters and/or metabolic enzymes and
particularly to the very high expression of the sodium-glucose co-
transporter SGLT2 and the glucose transporter GLUT1 in Jurkat
cells (Kaji et al., 2018), which may drive efficient glucose intake in
these cells.
Inefficient RVD following increases in the O-GlcNAcylation
of cellular proteins was linked to reduced intracellular water
diffusion (Nagy et al., 2010). During RVD, K+, Cl−, and other
intracellular osmolytes are lost, generating an osmotic water
efflux that permits cells to reduce their volume (Friedrich et al.,
2006). As water follows ions, one may speculate that reduced
intracellular water diffusion may arise from impaired ion fluxes.
Accordingly, pharmacological inhibition of swelling-activated
ion channels leads to increased cell swelling after hypotonic
stress and prevents RVD (Furst et al., 2002a), thus mimicking
the effect of an increased O-GlcNAcylation. Therefore, we
hypothesized that O-GlcNAcylation may alter RVD by inhibiting
ion transport. The finding that the protein ICln, essential in
the activation of the swelling-activated Cl− current IClswell, is
O-GlcNAc-modified (Hahne et al., 2013) further corroborated
this hypothesis. As expected, incubation of cells for 1 h
with 100 µM PUGNAc plus 5 mM glucosamine significantly
inhibited the ICln-induced IClswell (Figure 3), with no effect
on the endogenous IClswell (Supplementary Figure S4). Further
increase in O-GlcNAcylation obtained by OGT overexpression
inhibited both the ICln-induced current and the endogenous
IClswell current (Figures 2, 4). These findings suggest that
the majority of endogenous ICln is O-GlcNAcylated in basal
conditions and consequently unresponsive to relatively mild
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FIGURE 7 | Post-translational modification of ICln. (A) Identification of the O-GlcNAc site on ICln by LC-MS/MS. Product-ion spectra peptide 187–205 is displayed.
Fragmentation products of the O-GlcNAc-modified peptide is shown at the top (red) while the unmodified peptide fragments are shown on at the bottom (green) with
their corresponding monoisotopic mass m/z and charge-state (3+). The b- and y-ions are indicated with blue and red, respectively. (B) Amino acid sequence of
human ICln (NP_001284). Green and gray boxes represent β sheets and α helix secondary structure motifs of the pleckstrin-homology-like domain, respectively. The
predicted YinOYang site is in red and the amino acid sequence involved in the interaction with α-integrin is in green. Potential O-GlcNAcylation residues within the
O-GlcNAcylated fragment (187–205, highlighted in rose) are indicated in magenta, and the residue with the highest likelihood of phosphorylation (Thr223) within the
phosphorylated fragment (206–236, highlighted in cyan) is indicated in blue. Possible additional phosphorylation sites within this latter fragment are represented as
enlarged letters. The amino acids covered by MS are underlined and the fragment missing in the ICln mutant Ser193* is grayed out. MS, mass spectrometry.
increases in O-GlcNAcylation, while heterologous ICln is largely
unmodified. Experimental conditions that did not significantly
increase the O-GlcNAcylation levels of cellular proteins as
assessed by western blot (Figures 1A–C) failed to suppress
the ICln-induced current (Supplementary Figures S7–S9)
as well as the endogenous IClswell current (Supplementary
Figures S1–S3).
The identification of the O-GlcNAcylated proteins and
O-GlcNAcylated residues of a protein can be challenging.
O-GlcNAc modifications have low stoichiometry and generally
low abundance, and the extremely labile nature of O-GlcNAc
makes the determination of modification sites by conventional
tandem MS (MS/MS) difficult (Wang et al., 2014). Anti-O-
GlcNAc antibodies did not recognize ICln immunoprecipitated
from HEK 293 Phoenix cells, even following elevation of
O-GlcNAc levels (data not shown). Therefore, computational
methods remain an extremely useful tool in the identification
of potential O-GlcNAcylation sites (Jia and Zuo, 2018).
While MS evidenced that ICln is O-GlcNAc modified on
its C-terminus, this is unlikely involved in the suppression
of the ICln-induced current, as mutation or deletion of
the C-terminus did not abrogate responsiveness of the
ICln-induced current to O-GlcNAc elevation (Figure 9).
Therefore, we assume that the ICln O-GlcNAcylated site
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FIGURE 8 | Expression and function of ICln mutants. (A) HEK 293 Phoenix cells were transfected for 24 h with the indicated ICln mutants, wild-type ICln, or left
untransfected. The expression levels of ICln determined via western blot (left panel) were quantified by densitometry and normalized to the housekeeping protein
β-actin (right panel). n = 3 independent samples, *p < 0.05, one-way ANOVA with Dunnett’s post-test. (B–D) IClswell activation was monitored in HEK 293 Phoenix
cells transfected for 24 h with wild-type or mutant ICln or a control vector, as indicated. Single transfected cells were selected based on the fluorescence of the
transfection marker EGFP and voltage clamped using the whole-cell patch-clamp technique. The current density-to-voltage relationship (left panels) and the current
density-to-time relationship (right panels) determined after exposure to the extracellular hypotonic solution are shown. *p < 0.05, unpaired Student’s t-test. n.s., not
significant. (n) refers to the number of cells. EGFP, enhanced green fluorescent protein.
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FIGURE 9 | O-GlcNAc elevation inhibits IClswell in cells transfected with non-O-glycosylatable forms of ICln. IClswell activation was monitored in HEK 293 Phoenix
cells transfected for 24 h with (A) ICln Thr223Ala or (B) ICln Ser193* as well as the transfection marker EGFP as separate proteins and pre-incubated for 1 h with
100 µM PUGNAc plus 5 mM glucosamine or 0.1% DMSO plus 5 mM D-glucose as the control. Single transfected cells were selected and voltage clamped using
the whole-cell patch-clamp technique. The current density-to-voltage relationships determined in an extracellular hypotonic solution (left) and the current
density-to-time relationships (right) of IClswell in cells pre-incubated with 100 µM PUGNAc plus 5 mM glucosamine or the vehicle are shown. *p < 0.05, unpaired
Student’s t-test. (n) refers to the number of cells. EGFP, enhanced green fluorescent protein.
involved in the inhibition of the ICln-induced current
could not be detected by MS as the O-GlcNAc moiety was
most likely lost during sample preparation. In line with
this hypothesis, mutation of the predicted YinOYang site
on Ser67 conferred resistance of the ICln-induced current
to O-GlcNAc increases or decreases (Figure 10), strongly
suggesting that ICln is O-GlcNAc modified at Ser67. The
non-significant 38% decrease in the ICln Ser67Ala-induced
current observed in cells transfected with OGT most likely
reflected the effect of O-GlcNAc elevation on the endogenous
ICln (Figure 10B and Table 1).
The identification of a direct molecular interaction between
ICln and OGT confirmed that ICln is O-GlcNAc modified.
Mutation of Ser67 destabilized the interaction, suggesting that
this amino acid comes in close contact with OGT (Figure 11).
Substitution of Ser67 with an Ala should have minimal impact
on protein conformation, as the expression levels and activity
of ICln Ser67Ala are very similar to that of the wild-type
protein (Figures 8A,D). Therefore, alterations in interaction with
OGT and insensitivity of the ICln Ser67Ala-induced current to
O-GlcNAc are unlikely linked to a variation in protein folding
or stability and most likely reflect an impaired O-GlcNAcylation
following substitution of Ser67.
Intriguingly, Ser67 lies in close proximity with the amino acid
sequence (61)ISLHA(65), which binds the motif KXGFFKR of the
intracellular domain of α-integrin as an essential step in IClswell
activation (Schedlbauer et al., 2019). This observation prompted
us to investigate whether O-GlcNAcylation controls the binding
of ICln to integrin αIIb. Surprisingly, the FRET efficiency between
the non-glycosylatable ICln Ser67Ala and integrin αIIb was
approximately thrice that of the wild-type ICln, thus implying
a strong interaction (Figure 12A). This finding suggests that
O-GlcNAcylation prevents the interaction between wild-type
ICln and α-integrin and further confirms that wild-type ICln is,
at least in part, constitutively O-GlcNAcylated. While an increase
in the O-GlcNAcylation of cellular proteins significantly reduced
the direct molecular interaction between wild-type ICln and
αIIb, it did not affect ICln Ser67Ala (Figure 12C). In parallel, a
decrease in the O-GlcNAcylation of cellular proteins significantly
increased the interaction between wild-type ICln and αIIb, but
did not affect ICln Ser67Ala (Figure 12D). The unresponsiveness
of the interaction between ICln Ser67Ala and α-integrin to
changes in the O-GlcNAcylation levels reflects the insensitivity
of the ICln Ser67Ala-induced current to the same conditions
(Figure 10). Altogether, these results show that increases in the
O-GlcNAcylation of cellular proteins affect RVD by inhibiting
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FIGURE 10 | The ICln Ser67Ala-induced IClswell is unresponsive to variations in O-glycosylation of cellular proteins. IClswell activation was monitored in HEK 293
Phoenix cells transfected for 24 h with ICln Ser67Ala and the transfection marker dsRed as separate proteins and (A) pre-incubated for 1 h with 100 µM PUGNAc
plus 5 mM glucosamine or 0.1% DMSO plus 5 mM D-glucose as the control or (B) co-transfected with OGT or (C) OGA-L and the transfection marker EGFP. The
current density-to-voltage relationships determined in an extracellular hypotonic solution (left panels) and the current density-to-time relationships (right panels) of
IClswell are shown. (n) refers to the number of cells. DMSO, dimethyl sulfoxide; EGFP, enhanced green fluorescent protein. OGT, O-GlcNAc transferase; OGA,
O-GlcNAcase.
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FIGURE 11 | ICln interacts with OGT. HeLa cells were transfected for 48 h with the FRET acceptors EYFP-OGT, OGT-EYFP, or EYFP as a negative control. (A) The
expression levels of O-GlcNAc-modified cellular proteins were determined via western blot (left panel), quantified by densitometry and normalized to the
housekeeping protein β-actin (middle panel). n = 3 independent samples. The protein pairs selected for FRET experiments are shown (right panel). (B) Left panel:
single cells transfected with the indicated FRET protein pairs were imaged before (pre) and after (post) photobleaching of the FRET acceptor. Green squares
correspond to the bleaching ROI and numbers correspond to the FRET efficiency determined in those ROIs. Scale bar: 10 µm. Right panel: FRET efficiency
determined within the bleaching ROIs between the indicated protein pairs. (n) refers to the number of cells from four subcultures. **p < 0.01, *p < 0.05, one-way
ANOVA with Dunnett’s post-test. n.s., not significant; OGT, O-GlcNAc-transferase; FRET, fluorescence resonance energy transfer; EYFP, enhanced yellow
fluorescent protein; ROI, region of interest.
IClswell; IClswell inhibition may derive from O-GlcNAcylation
of the protein ICln, with consequent loss of function due to
destabilization of the interaction with α-integrin; Ser67 controls
the ICln binding to integrin by conferring responsiveness of
this interaction to O-GlcNAcylation, thus indicating that this
or another amino acid located in close proximity most likely
represent an O-GlcNAcylation site.
An increase in the extracellular osmolarity resulted in an
increase in the O-GlcNAcylation levels of cellular proteins
in mouse embryonic fibroblasts (Zachara et al., 2004), while
exposure of HEK293T cells and primary mouse cortical neurons
to a hypotonic medium decreased O-GlcNAcylation, as a
result of a decline in OGT expression (Kommaddi et al.,
2011). Accordingly, we found that exposure of HeLa cells
to hypotonicity significantly reduced cellular O-GlcNAcylation
abundance (Figure 13). This event would permit an activation
of ICln and, hence, IClswell and RVD, following hypotonic
stress. As detailed above, several points of evidence indicate
that, in the absence of hypotonic stress, ICln is kept inactive by
constitutive O-GlcNAcylation. This concept is further supported
by the existence of a significant FRET between ICln and OGT in
an isotonic environment, while an interaction with OGA could
not be detected in the same condition (Figure 11). Altogether,
our findings indicate that hypotonicity would lead to IClswell
activation via reduction of ICln O-GlcNAcylation at Ser67,
which would permit its direct binding to α-integrin through the
neighboring (61)ISLHA(65) motif.
The amino acid sequence (61)ISLHA(65) appears to be
crucial in controlling the interaction between ICln and its
molecular partners. As multifunctional protein and connector
hub, ICln exerts multiple roles within distinct functional
modules by interacting with heterogeneous protein targets
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FIGURE 12 | O-GlcNAcylation controls the interaction of ICln with α-integrin. (A) NIH/3T3 cells were transfected for 48 h with the FRET acceptor αIIbshort-EYFP and
ECFP-ICln wild type or Ser67Ala, or with ECFP as a control, and imaged before (pre) and after (post) photobleaching of the FRET acceptor. FRET efficiency was
determined in three–four regions of interest (ROIs) of the plasma membrane of each cell. (B) The O-GlcNAcylation levels were left unmodified or (C) increased by
incubation of cells with 100 µM PUGNAc plus 5 mM glucosamine for 1 h. The vehicle was 0.1% DMSO plus 5 mM D-glucose. (D) The O-GlcNAcylation levels were
reduced by co-transfection of cells with OGA-L and the transfection marker dsRed as separated proteins. (n) refers to the number of ROIs of cells from at least four
subcultures. ***p < 0.001, **p < 0.01, *p < 0.05, one-way ANOVA with Dunnett’s post-test. FRET, fluorescence resonance energy transfer; EYFP, enhanced yellow
fluorescent protein; ECFP, enhanced cyan fluorescent protein; DMSO, dimethyl sulfoxide.
(Furst et al., 2006). In addition to its function in the regulation
of cellular volume, ICln acts as an assembly chaperone and
Smith antigen (Sm) protein mimic and enables the assembly
of the 6S core of the small nuclear ribonucleoproteins
(snRNP), which are a key component of the spliceosome
(Grimm et al., 2013). Within the ring structure of the 6S
complex, ICln establishes a direct molecular interaction with
SmD1 and SmG. The ICln–SmD1 interaction interface is
centered on the antiparallel β-strand pair represented by the
SmD1 β4 and the ICln β5. This interaction involves the
formation of five backbone–backbone H-bonds involving the
residues (61)ISLHA(65) of ICln. A sixth H-bond is formed
between the side-chain hydroxyl group of ICln Ser67 and the
backbone carbonyl of SmD1 Gln54. Therefore, it is likely that
O-GlcNAcylation of Ser67 also affects the interaction between
ICln and SmD1.
In line with our findings, other studies have shown that
RVD and IClswell magnitude were reduced in mouse models
of diabetes mellitus, a condition where O-GlcNAc is chronically
elevated. For example, in white adipocytes isolated from yellow
Kuo Kondo (KKAy) diabetic mice, RVD rate and IClswell
magnitude were lower than those measured in adipocytes of
normal C57BL/6 or KK mice, a parental strain of KKAy mice that
do not manifest diabetes until an older age (Inoue et al., 2010).
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FIGURE 13 | Hypotonicity reduces the cellular O-GlcNAcylation levels. Immunofluorescence images of ICln and O-GlcNAc proteins in HeLa cells exposed to
hypotonic stress. HeLa cells were pre-treated with the vehicle or 100 µM PUGNAc and 5 mM glucosamine (GlcN) and then exposed to normotonic (300 mOsmol) or
hypotonic (200 mOsmol) conditions. (A) Representative confocal images of cells labeled with anti-ICln (green) and CTD110.6 (anti-O-GlcNAc, red) antibodies and
corresponding merged images. Scale bar: 20 µM. (B) Bar graph shows the average fluorescence intensity of cells normalized to control levels. Each bar represents
the average fluorescence of at least 60 cells. Data are shown as means ± SD, **p < 0.01, ***p < 0.001, one-way ANOVA with Dunnett’s post-test.
Accordingly, RVD was almost lost and IClswell magnitude was
significantly reduced in ventricular myocytes of streptozotocin-
induced mice, a well-established model of type 1 diabetes
(Yamamoto et al., 2009). Importantly, the RVD rate was
heavily reduced also in platelets derived from diabetic patients
(Margalit et al., 1995). However, the cellular O-GlcNAc levels
in these three latter studies were not measured, and the
possible link between increased O-GlcNAc and impaired RVD
was not assessed.
As already mentioned, O-GlcNAc modification is involved in
the development of insulin resistance and chronic complications
of diabetes mellitus (Vaidyanathan and Wells, 2014; Peterson
and Hart, 2016), which could in principle be correlated to
an impairment of RVD and/or IClswell. Diabetic nephropathy
is a clinical syndrome characterized by kidney damage and
may result in renal failure (Sun et al., 2013). The cellular
and molecular mechanisms leading to diabetic nephropathy
are complex and only partially understood. Although the
glomerulus has historically been considered as the primary site
of diabetic kidney injury, it is becoming increasingly evident
that hyperglycemia-induced tubular lesions are prominent
components of diabetic nephropathy (Bagby, 2007; Tang and
Lai, 2012). The kidney plays the crucial function of controlling
the systemic blood pressure and electrolyte balance and is
often subjected to osmotic stress during the phenomena of
diuresis and anti-diuresis. In addition, in diabetes mellitus, high
levels of glucose in the glomerular filtrate lead to an increased
reabsorption of glucose and sodium by SGLT2 and SGLT1 in
the proximal tubule, along with passive reabsorption of chloride
and water (Vallon and Thomson, 2020). It is well known that
cells in absorptive epithelia need to efficiently regulate their
volume following increases in the intracellular concentration
of osmo-active substances, including glucose (van der Wijk
et al., 2000). Therefore, although pathological changes like
renal fibrosis, mesangial expansion, glomerular hypertrophy,
inflammation, and oxidative stress seem to be the main events
leading to diabetic nephropathy (Bhattacharjee et al., 2016),
we suggest that an impaired or insufficient RVD of kidney
tubular cells, which leads to necrotic cell death (Okada et al.,
2001, 2019), may contribute to the development of kidney
damage in the context of uncontrolled or poorly controlled
diabetes mellitus.
Former studies exploring the role of O-GlcNAc in diabetic
nephropathy mimicked hyperglycemic conditions by exposing
various cell types to 20–35 mM D-glucose for 24–48 h (Park
et al., 2014; Eleftheriadis et al., 2016, 2020; Gellai et al., 2016).
The relatively short incubation time used in the present work
(1 h) aimed at disclosing early pathophysiological changes prior
overt derangements of cell homeostatic functions occurred.
HEK 293 cells, which originate from embryonic kidney, are
probably largely undifferentiated but show characteristics of renal
epithelial cells and express markers of the proximal tubule, such
as SGLT1 (Kaji et al., 2018). HEK 293 cells behavior did not
significantly differ from that of HK2 cells—an immortalized
proximal tubule epithelial cell line, in an in vitro model of diabetic
nephropathy (Masola et al., 2011). Other cells used in the present
work were chosen as a convenient overexpression system of
ectopic proteins. It would be important to confirm the findings
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presented here, and especially a GlcNAc-induced alteration in
RVD, in better models of kidney tubular cells, such as primary
human renal proximal tubular epithelial cells.
ICln interacts with multiple partner proteins to participate
in multiple cellular functions (Furst et al., 2006). It is
tempting to speculate that phosphorylation of Thr223 and/or
O-GlcNAc modification of the C-terminus of ICln might
control its interactome. Further studies are needed to explore
this hypothesis.
In conclusion, an increased O-GlcNAcylation of cellular
proteins leads to impairment of the homeostatic reaction
of RVD by suppressing the swelling-activated chloride
current IClswell. IClswell suppression is linked to an
inhibition of function of the protein ICln subsequent to
O-GlcNAcylation at Ser67, which leads to destabilization
of its direct interaction with the intracellular domain of
α-integrin. These results underscore the essential role of
O-GlcNAc modification in governing basic cell homeostatic
functions by controlling protein–protein interactions, and
further suggest that reducing ICln O-GlcNAcylation may
represent a novel strategy in the prevention or treatment
of diseases where an RVD derangement might be involved,
including chronic complications of diabetes mellitus such as
diabetic nephropathy.
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